0001231919-20-000056.txt : 20200825 0001231919-20-000056.hdr.sgml : 20200825 20200825142402 ACCESSION NUMBER: 0001231919-20-000056 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200825 DATE AS OF CHANGE: 20200825 EFFECTIVENESS DATE: 20200825 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pyros Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001809245 IRS NUMBER: 821881210 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-364840 FILM NUMBER: 201131412 BUSINESS ADDRESS: STREET 1: 333 W 39TH STREET STREET 2: SUITE 303 CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: 201-743-9468 MAIL ADDRESS: STREET 1: 333 W 39TH STREET STREET 2: SUITE 303 CITY: NEW YORK STATE: NY ZIP: 10018 D/A 1 primary_doc.xml X0708 D/A LIVE 0001809245 Pyros Pharmaceuticals, Inc. 333 W 39TH STREET SUITE 303 NEW YORK NY NEW YORK 10018 201-743-9468 DELAWARE Pyros Pharmaceuticals LLC None Corporation true 2019 Michael Smith c/o Pyros Pharmaceuticals, Inc. 333 W 39th Street, Suite 303 New York NY NEW YORK 10018 Executive Officer Director Edwin Urrutia c/o Pyros Pharmaceuticals, Inc. 333 W 39th Street, Suite 303 New York NY NEW YORK 10018 Executive Officer Director Other Decline to Disclose 06b true 0001809245-20-000001 2020-03-31 false true true false 0 Paulson Investment Company, LLC 5670 None None 5335 Meadows Road Suite 465 Lake Oswego OR OREGON 97035 All States false 6000000 5935000 65000 false 59 780000 true 0 0 false Pyros Pharmaceuticals, Inc. /s/ Michael Smith Michael Smith Chief Executive Officer 2020-08-25